The aim of this study was to test the hypothesis that individuals with an increase in HbA1c (i.e. above the regular but below the diabetic threshold) exhibit an impairment in the Achilles tendon structure and walking capacity, due to the adverse effect of the advanced glycation end-product. One hundred fifty-eight participants matched for gender, age, physical activity and BMI, were divided in two cohorts based on the HbA1c level: normal HbA1c (NGH; <39 mmol/molHb; n = 79) and altered HbA1c (AGH; >=39 mmol/molHb; n = 79). Each participant performed several walking trials to evaluate the kinematic parameters during walling at the self-selected speed and a quantitative MRI scan of the Achilles tendon (AT) to obtain its intrinsic characteristics (i.e. T2* relaxation time short and long component). The AT T2* relaxation time short component (a parameter related to the tendon collagen quality) was reduced in AGH compared to NGH. Furthermore, AGH exhibited a slower self-selected walking speed (NGH: 1.59 ± 0.18 m/s; AGH:1.54 ± 0.16 m/s) and a shorter stride length (NGH: 1.59 ± 0.13 m; AGH:1.55 ± 0.11 m). Our data suggest that a non-pathological increase in HbA1c is able to negatively affect AT collagen quality and walking capacity in healthy people. These results highlight the importance of glycemic control, even below the pathological threshold. Since diabetes could alter several biological pathways, further studies are necessary to determine which mechanisms and their timing, regarding the HbA1c rise, affect tendon composition and, consequently, walking capacity.

Department of Neurosciences Biomedicine and Movement Sciences University of Verona Verona Italy

Human Motion Diagnostic Center Department of Human Movement Studies University of Ostrava 70200 Ostrava Czech Republic

See more in PubMed

Brownlee, M., Cerami, A. & Vlassara, H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl. J. Med.318, 1315–1321 (1988). PubMed

Brownlee, M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med.46, 223–234 (1995). PubMed

Suzuki, A., Yabu, A. & Nakamura, H. Advanced glycation end products in musculoskeletal system and disorders. Methods203, 179–186 (2022). PubMed

Bai, P., Phua, K., Hardt, T., Cernadas, M. & Brodsky, B. Glycation alters collagen fibril organization. Connect. Tissue Res.28, 1–12 (1992). PubMed

Odetti, P. et al. Scanning force microscopy reveals structural alterations in diabetic rat collagen fibrils: role of protein glycation. Diabetes Metab. Res. Rev.16, 74–81 (2000). PubMed

Rosenthal, A. K., Gohr, C. M., Mitton, E., Monnier, V. & Burner, T. Advanced glycation end products increase transglutaminase activity in primary porcine tenocytes. J. Investig Med.57(2), 460–466 (2009). PubMed PMC

Snow, L. M. & Thompson, L. V. Influence of insulin and muscle fiber type in Nε-(carboxymethyl)-lysine accumulation in soleus muscle of rats with streptozotocin-induced diabetes mellitus. Pathobiology. 76, 227–234 (2009). PubMed PMC

Chiu, C. Y. et al. Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway. J. Pathol.238, 470–482 (2016). PubMed

Burner, T., Gohr, C., Mitton-Fitzgerald, E. & Rosenthal, A. K. Hyperglycemia reduces proteoglycan levels in tendons. Connect. Tissue Res.53, 535–541 (2012). PubMed

Grant, W. P. et al. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J. Foot Ankle Surg.36(4), 272–278 (1997). PubMed

Couppé, C. et al. Human Achilles tendon glycation and function in diabetes. J. Appl. Physiol.120, 130–137 (2016). PubMed

Petrovic, M. et al. Altered Achilles tendon function during walking in people with diabetic neuropathy: implications for metabolic energy saving. J. Appl. Physiol.124, 1333–1340 (2018). PubMed

Cronin, N. J. et al. Achilles tendon length changes during walking in long-term diabetes patients. Clin. Biomechh. 25, 476–482 (2010). PubMed

Primadhi, R. & Rasyid, H. Is elevated Hba1c level associated with Achilles tendon contracture development in diabetic foot patients?? Malays Orthop. J.16, 70–75 (2022). PubMed PMC

Martinelli, A. R. et al. Muscle strength and ankle mobility for the gait parameters in diabetic neuropathies. Foot23, 17–21 (2013). PubMed

Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J. & Kivimäki, M. Prediabetes: a high-risk state for diabetes development. Lancet379, 2279–2290 (2012). PubMed PMC

Colberg, S. R. et al. Physical activity/exercise and diabetes: A position statement of the American diabetes association. Diabetes Care. 39(11), 2065–2079 (2016). PubMed PMC

Skovgaard, D. et al. Chronic hyperglycemia, hypercholesterolemia, and metabolic syndrome are associated with risk of tendon injury. Scand. J. Med. Sci. Sports. 31, 1822–1831 (2021). PubMed

Monnier, V. M. et al. Cross-linking of the extracellular matrix by the Maillard reaction in aging and diabetes: an update on ‘a puzzle nearing resolution’. Ann. N Y Acad. Sci.1043, 533–544 (2005). PubMed

Fessel, G. et al. Advanced glycation end-products reduce collagen molecular sliding to affect collagen fibril damage mechanisms but not stiffness. PLoS One. 9(11), e110948 (2014). PubMed PMC

Monte, A., Skypala, J., Vilimek, D., Juras, V. & Jandacka, D. Correlations between Achilles tendon material and structural properties and quantitative magnetic resonance imagining in different athletic populations. J. Biomech.159, 111796 (2023). PubMed

Cipryan, L. et al. Regular running in an air-polluted environment: physiological and anthropometric protocol for a prospective cohort study (Healthy aging in industrial environment Study – Program 4). BMJ Open.10, e040529 (2020). PubMed PMC

Jandacka, D. et al. Running and physical activity in an air-polluted environment: the Biomechanical and musculoskeletal protocol for a prospective cohort study 4HAIE (Healthy aging in industrial Environment—Program 4). Int. J. Environ. Res. Public. Health. 17(23), 9142 (2020). PubMed PMC

Elavsky, S. et al. Physical activity in an air-polluted environment: behavioral, psychological and neuroimaging protocol for a prospective cohort study (Healthy aging in industrial environment study – Program 4). BMC Public. Health. 21, 126 (2021). PubMed PMC

Sun, H. et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract.183, (2022). PubMed PMC

Wiegand, K. et al. Running status and history: A self-report study. Phys. Ther. Sport. 39, 8–15 (2019). PubMed

Apprich, S. et al. The Vienna morphological Achilles tendon score—VIMATS: description, reproducibility and initial clinical results. Wien Klin. Wochenschr. 133, 560–567 (2021). PubMed PMC

Stofan, J. R., DiPietro, L., Davis, D., Kohl, H. W. & Blair, S. N. Physical activity patterns associated with cardiorespiratory fitness and reduced mortality: the aerobics center longitudinal study. Am. J. Public. Health. 88, 1807–1813 (1998). PubMed PMC

Palosuo, T., Husman, T., Koistinen, J. & Aho, K. C-reactive protein in population samples. Acta Med. Scand.220(2), 175–179 (1986). PubMed

Malus, J. et al. Marker placement reliability and objectivity for biomechanical cohort study: healthy aging in industrial environment (HAIE—Program 4). Sensors21(5), 1830 (2021). PubMed PMC

Stanhope, S. J., Kepple, T. M., McGuire, D. A. & Roman, N. L. Kinematic-based technique for event time determination during gait. Med. Biol. Eng. Comput.28, 355–360 (1990). PubMed

Cohen, J. Statistical Power Analysis for the Behavioral Sciences (L. Erlbaum Associates, 1988).

Ahima, R. S. Overview of metabolic syndrome. In Metabolic Syndrome: A Comprehensive Textbook (ed Ahima, R. S.) 3–14 (Springer International Publishing, 2023).

Juras, V. et al. Regional variations of T2* in healthy and pathologic Achilles tendon in vivo at 7 Tesla: preliminary results. Magn. Reson. Med.68, 1607–1613 (2012). PubMed

Qian, Y., Williams, A. A., Chu, C. R. & Boada, F. E. Repeatability of ultrashort echo time-based two-component T2* measurements on cartilages in human knee at 3 T. Magn. Reson. Med.69, 1564–1571 (2013). PubMed PMC

Juras, V. et al. Bi-exponential T2* analysis of healthy and diseased Achilles tendons: an in vivo preliminary magnetic resonance study and correlation with clinical score. Eur. Radiol.23, 2814–2822 (2013). PubMed PMC

DeGroot, J. et al. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: the role of nonenzymatic glycation. Arthritis Rheum.42, 1003–1009 (1999). PubMed

DeGroot, J. et al. Accumulation of advanced glycation endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage. Osteoarthr. Cartil.9, 720–726 (2001). PubMed

Rees, S. G., Dent, C. M. & Caterson, B. Metabolism of proteoglycans in tendon. Scand. J. Med. Sci. Sports. 19, 470–478 (2009). PubMed

Patel, S. H. et al. Advanced glycation end-products suppress mitochondrial function and proliferative capacity of Achilles tendon-derived fibroblasts. Sci. Rep.9(1), 12614 (2019). PubMed PMC

Mifune, Y. et al. Influence of advanced glycation end products on rotator cuff. J. Shoulder Elb. Surg.28, 1490–1496 (2019). PubMed

Qian, Y., Williams, A. A., Chu, C. R., Boada, F. E. & Multi-Component, T. 2* mapping of knee cartilage: technical feasibility ex vivo. Magn. Reson. Med.64(5), 1426–1431 (2010). PubMed PMC

Claessen, F. M. A. P., de Vos, R. J., Reijman, M. & Meuffels, D. E. Predictors of primary Achilles tendon ruptures. Sports Med.44, 1241–1259 (2014). PubMed

Magnusson, S. P. et al. Collagen fibril size and crimp morphology in ruptured and intact Achilles tendons. Matrix Biol.21, 369–377 (2002). PubMed

Schrack, J. A., Zipunnikov, V., Simonsick, E. M., Studenski, S. & Ferrucci, L. Rising energetic cost of walking predicts gait speed decline with aging. J. Gerontol. Ser. A. 71(7), 947–953 (2016). PubMed PMC

Brown, S. J. et al. Do patients with diabetic neuropathy use a higher proportion of their maximum strength when walking? J. Biomech.47, 3639–3644 (2014). PubMed